We are live on
!
Find out more
VIA
Virtus Investment Advisers Portfolio holdings
AUM
$363M
1-Year Est. Return
34.89%
This Fund
S&P 500
This Quarter
Est. Return
+9.26%
1 Year Est. Return
+34.89%
3 Year Est. Return
+131.43%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$296M
AUM Growth
-$72M
(-20%)
Cap. Flow
-$84.2M
Cap. Flow
% of AUM
-28.48%
Top 10 Holdings %
Top 10 Hldgs %
6.88%
Holding
509
New
39
Increased
197
Reduced
202
Closed
70
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Constellation Energy
CEG
|
+$1.64M |
| 2 |
Veeva Systems
VEEV
|
+$1.51M |
| 3 |
Cisco
CSCO
|
+$1.5M |
| 4 |
Fox Class A
FOXA
|
+$1.48M |
| 5 |
DoorDash
DASH
|
+$1.48M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Virtus Newfleet ABS/MBS ETF
VABS
|
+$32.2M |
| 2 |
Virtus Newfleet Short Duration High Yield Bond ETF
VSHY
|
+$24.6M |
| 3 |
Virtus SEIX Senior Loan ETF
SEIX
|
+$19M |
| 4 |
SMC
Summit Midstream
SMC
|
+$3.67M |
| 5 |
State Street SPDR Bloomberg High Yield Bond ETF
JNK
|
+$2.09M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 33.24% |
| 2 | Healthcare | 17.43% |
| 3 | Technology | 12.41% |
| 4 | Industrials | 9.1% |
| 5 | Consumer Discretionary | 4.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Xencor
XNCR
$1.55B
| $78.4K | 0.03% |
9,972
+3,338
| +50% | +$30K |
|
427
Erasca
ERAS
$6.39B
| $78.1K | 0.03% |
61,459
-962
| -2% | -$1.29K |
|
|
MTSR
428
DELISTED
Metsera Inc
MTSR
| $77.4K | 0.03% |
+2,719
| New | +$67.5K |
|
429
Allogene Therapeutics
ALLO
$694M
| $75.9K | 0.03% |
67,166
-14,104
| -17% | -$18.7K |
|
430
Regenxbio
RGNX
$708M
| $75.7K | 0.03% |
9,219
-9,611
| -51% | -$80.5K |
|
|
TRML
431
DELISTED
Tourmaline Bio
TRML
| $75.6K | 0.03% |
4,725
-2,564
| -35% | -$41.5K |
|
|
BCAX
432
Bicara Therapeutics
BCAX
$1.84B
| $75.5K | 0.03% |
8,127
-970
| -11% | -$11.6K |
|
|
BCYC
433
Bicycle Therapeutics
BCYC
$292M
| $75.2K | 0.03% |
10,821
+2,659
| +33% | +$21.2K |
|
434
Rocket Pharmaceuticals
RCKT
$394M
| $75K | 0.03% |
30,630
+17,572
| +135% | +$89K |
|
435
Neurogene
NGNE
$712M
| $68.9K | 0.02% |
4,609
-2,742
| -37% | -$43K |
|
436
Capricor Therapeutics
CAPR
$237M
| $67K | 0.02% |
6,746
-4,702
| -41% | -$49.7K |
|
437
Dyne Therapeutics
DYN
$4.9B
| $61.9K | 0.02% |
6,503
+90
| +1% | +$991 |
|
|
CMPS
438
Compass Pathways
CMPS
$1.83B
| $58.3K | 0.02% |
20,804
-16,421
| -44% | -$61.8K |
|
439
Altimmune
ALT
$599M
| $50.9K | 0.02% |
13,151
-5,965
| -31% | -$32.3K |
|
440
Arthur J. Gallagher & Co
AJG
$63.6B
| – | – |
-4,841
| Closed | -$1.67M |
|
441
Applied Materials
AMAT
$428B
| – | – |
-8,221
| Closed | -$1.19M |
|
442
Ametek
AME
$58.2B
| – | – |
-7,770
| Closed | -$1.34M |
|
443
Amazon
AMZN
$2.96T
| – | – |
-5,969
| Closed | -$1.14M |
|
444
Aon
AON
$76B
| – | – |
-3,826
| Closed | -$1.53M |
|
445
Invesco Senior Loan ETF
BKLN
$6.74B
| – | – |
-47,975
| Closed | -$993K |
|
|
BPMC
446
DELISTED
Blueprint Medicines
BPMC
| – | – |
-3,878
| Closed | -$343K |
|
447
Carrier Global
CARR
$52.8B
| – | – |
-21,112
| Closed | -$1.34M |
|
448
Perspective Therapeutics
CATX
$342M
| – | – |
-47,307
| Closed | -$101K |
|
449
BlackRock ETF Trust II iShares AAA CLO Active ETF
CLOA
$2.26B
| – | – |
-22,765
| Closed | -$1.18M |
|
450
Chipotle Mexican Grill
CMG
$41.5B
| – | – |
-24,567
| Closed | -$1.23M |
|
Similar funds
RC
MS
WI
HS
SIAG
WTFG
A6
ACM
Virtus Investment Advisers's Q2 2025 Portfolio in Review
As of Q2 2025, Virtus Investment Advisers held 509 positions worth $296M, down 20% from $368M the previous quarter. Its ten largest holdings account for 6.9% of the portfolio.
Virtus Investment Advisers withdrew a net $84.2M in Q2 2025, closing 70 positions and reducing 202 holdings. Its most notable exit was Virtus Newfleet ABS/MBS ETF, an estimated $32.2M position sold in full.
By sector, the portfolio is most concentrated in Financials at 33% of assets, up from 24% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Virtus Investment Advisers opened a new position in Constellation Energy worth $2.01M.
- Virtus Investment Advisers's largest Q2 2025 buy was Constellation Energy: 6,213 shares worth $2.01M.
- Virtus Investment Advisers added most to Amgen in Q2 2025, an estimated $1.45M increase.
- Virtus Investment Advisers's biggest Q2 2025 reduction was EOG Resources, cutting an estimated $1.23M.
- Virtus Investment Advisers fully exited Virtus Newfleet ABS/MBS ETF in Q2 2025, selling an estimated $32.2M.
- Virtus Investment Advisers's ten largest holdings make up 6.9% of its $296M portfolio in Q2 2025.
- Virtus Investment Advisers opened 39 new positions and closed 70 in Q2 2025.
- Virtus Investment Advisers's portfolio value fell 20% quarter-over-quarter to $296M.
Based on Virtus Investment Advisers's 13F filing for Q2 2025, filed 13 Aug 2025.